Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)-Reference-Cited by-同舟云学术

Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

Published:2016-12-25 Issue:4 Volume:22 Page:443-449
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Lee Hye Won,Park Jun Yong,Kim Beom Kyung,Kim Moon Young,Lee Jung Il,Kim Young Suk,Yoon Ki Tae,Han Kwang-Hyub,Ahn Sang Hoon

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://e-cmh.org/upload/pdf/cmh-2016-0037.pdf

Reference30 articles.

1. Hepatitis B Virus Infection — Natural History and Clinical Consequences

2. Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level

3. Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load

4. Update on hepatitis B virus infection

5. Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entecavir versus tenofovir on the recurrence of hepatitis B–related HCC after liver transplantation: A multicenter observational study;Liver Transplantation;2023-07-26

2. Comparing the efficacy and safety of tenofovir and adefovir or combined drug treatment for the treatment of chronic hepatitis B infection: a systematic review and meta-analysis;Annals of Translational Medicine;2022-09

3. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01

4. Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?;Clinical and Molecular Hepatology;2020-07-01

5. Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection;Clinical Gastroenterology and Hepatology;2019-06